Diagnostics News and Research

RSS

Novavax first quarter net loss decreases to $7.5 million

Novavax, Inc. today announced its financial results for the first quarter ended March 31, 2011.

9 May 2011

Illumina announces price reduction in whole human genome sequencing projects

Illumina, Inc. today announced that it is significantly reducing the price for sequencing whole human genomes through the Illumina Genome Network.

From Illumina, Inc. 9 May 2011

caprotec bioanalytics closes Series B financing for EUR 5 million

caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Epigenomics AG, the cancer molecular diagnostics company, reports that Dr. Uri Ladabaum, Associate Professor in the Department of Gastroenterology and Hepatology at the School of Medicine of Stanford University, has presented the results of a health economic analysis of potential future colorectal cancer screening with Septin9 blood tests at the ongoing Digestive Disease Week 2011.

9 May 2011

Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia

Merrimack Pharmaceuticals, Inc. and PharmaEngine, Inc. today announced the signing of an agreement under which Merrimack has acquired the rights to develop and commercialize MM-398 in Europe and Asia.

9 May 2011

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

Epigenomics AG, the cancer molecular diagnosis company, today announced the signing of a supply agreement with Life Technologies Corporation, a global provider of innovative life science solutions.

7 May 2011

MicroPhage receives FDA clearance for KeyPath MRSA/MSSA Blood Culture Test

The U.S. Food and Drug Administration today cleared the first test for Staphylococcus aureus infections that is able to quickly identify whether the bacteria are methicillin resistant or methicillin susceptible.

7 May 2011

Novartis receives FDA approval for Afinitor to treat pancreatic neuroendocrine tumors

Yesterday, the U.S. Food and Drug Administration approved the Novartis drug Afinitor for the treatment of advanced pancreatic neuroendocrine tumors.

7 May 2011

FDA approves Abbott's RX ACCULINK Carotid Stent System

Abbott today announced that the U.S. Food and Drug Administration approved the RX ACCULINK Carotid Stent System for the treatment of patients with carotid artery disease who are at standard risk of adverse events from carotid endarterectomy.

7 May 2011

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

Roche announced today that it has filed for FDA clearance of its Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) tests.

7 May 2011

AdvanSource Biomaterials enters multi-year supply agreement with global coated medical devices company

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced it has entered into a multi-year supply agreement with an international medical diagnostics device company engaged in the business of developing medical device coatings and developing, manufacturing and selling coated medical devices.

6 May 2011

BD MAX Open System for molecular testing launched in Europe

BD Diagnostics, a segment of BD, today announced the European launch of the BD MAX™ Open System for molecular testing, which will enable laboratories to run both laboratory and BD- developed assays and offer enhanced testing services that elevate the standards of care at their institutions.

From BD (Becton, Dickinson and Company) 6 May 2011

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced the availability in Europe of the Simplexa C. difficile Universal Direct test on the 3M Integrated Cycler.

From Quest Diagnostics 6 May 2011

EraGen workshop to address two topics on real-time PCR-based viral monitoring tests

EraGen Biosciences Inc. today announced that it will host a corporate workshop at the upcoming Clinical Virology Symposium, which is being held May 8-11 in Daytona Beach, Fla. The workshop will take place at 1 p.m. on Tuesday, May 10, at the Ocean Center in Daytona Beach.

5 May 2011

Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases

Debiopharm Group, a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Yale University, a premier university with a long tradition of both basic and clinically directed biomedical research, announce an exclusive worldwide license agreement concerning the development and commercialization of Debio 1036, a first-in-class inhibitor for autoimmune and inflammatory diseases.

4 May 2011

ChipDX identifies gene expression signature in early-stage breast tumors

ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.

4 May 2011

Aleris reaches agreement to acquire Proxima

Aleris, an operating subsidiary to Investor, has reached an agreement to acquire Swedish healthcare provider Proxima Intressenter AB for an enterprise value of SEK 1,080 m.

4 May 2011

WWP2 protein appears to play a key role in tumor survival

A protein known as WWP2 appears to play a key role in tumor survival, a research team headed by a scientist at The University of Texas MD Anderson Cancer Center reports in an advance online publication of Nature Cell Biology.

4 May 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.

3 May 2011

Diagnostics News and Research

Novavax first quarter net loss decreases to $7.5 million

Illumina announces price reduction in whole human genome sequencing projects

caprotec bioanalytics closes Series B financing for EUR 5 million

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Epigenomics presents Septin9 blood test study data in colorectal cancer at DDW 2011

Merrimack acquires development and commercialization rights to MM-398 in Europe, Asia

Epigenomics, Life Technologies enter supply agreement for second-generation colorectal cancer blood test

MicroPhage receives FDA clearance for KeyPath MRSA/MSSA Blood Culture Test

Novartis receives FDA approval for Afinitor to treat pancreatic neuroendocrine tumors

FDA approves Abbott's RX ACCULINK Carotid Stent System

Roche seeks FDA clearance for fully automated Chlamydia and gonorrhoeae test

AdvanSource Biomaterials enters multi-year supply agreement with global coated medical devices company

BD MAX Open System for molecular testing launched in Europe

Quest Diagnostics' Simplexa C. difficile test is now available in Europe

EraGen workshop to address two topics on real-time PCR-based viral monitoring tests

Yale, Debiopharm partner to develop and commercialize Debio 1036 for inflammatory diseases

ChipDX identifies gene expression signature in early-stage breast tumors

Aleris reaches agreement to acquire Proxima

WWP2 protein appears to play a key role in tumor survival

U.Va, Coulter Foundation partner for translational research in biomedical engineering

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News